2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors.

2-(2-Chloro-6-fluorophenyl)acetamides having 2,2-difluoro-2-aryl/heteroaryl-ethylamine P3 and oxyguanidine P1 substituents are potent thrombin inhibitors (K(i)=0.9-33.9 nM). 2-(5-Chloro-pyridin-2-yl)-2,2-difluoroethylamine was the best P3 substituent, yielding the most potent inhibitor (K(i)=0.7 nM). Replacing the P3 heteroaryl group with a phenyl ring or replacing the difluoro substitution with dimethyl or cyclopropyl groups in the linker reduced the affinity for thrombin significantly. The aminopyridine P1s also provided an increase in potency.

[1]  J. Vacca,et al.  Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templates. , 1998, Journal of medicinal chemistry.

[2]  Youwei Yan,et al.  Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamides. , 2003, Bioorganic & medicinal chemistry letters.

[3]  G. Vlasuk Structural and Functional Characterization of Tick Anticoagulant Peptide (TAP): A Potent and Selective Inhibitor of Blood Coagulation Factor Xa , 1993, Thrombosis and Haemostasis.

[4]  W. M. Sanders,et al.  Azaindoles: moderately basic P1 groups for enhancing the selectivity of thrombin inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[5]  Ingemar Nilsson,et al.  A new oral anticoagulant: the 50-year challenge , 2004, Nature Reviews Drug Discovery.

[6]  G. Petsko,et al.  Weakly polar interactions in proteins. , 1988, Advances in protein chemistry.

[7]  David J. Miller,et al.  Sequential (.pi.-allyl)palladium alkylations , 1982 .

[8]  J. Hauptmann Pharmacokinetics of an emerging new class of anticoagulant/antithrombotic drugs , 2001, European Journal of Clinical Pharmacology.

[9]  Mitchell R Seim,et al.  Application of the Goldilocks effect to the design of potent and selective inhibitors of phenylethanolamine N-methyltransferase: balancing pKa and steric effects in the optimization of 3-methyl-1,2,3,4-tetrahydroisoquinoline inhibitors by beta-fluorination. , 2006, Journal of medicinal chemistry.

[10]  J. Howard,et al.  How good is fluorine as a hydrogen bond acceptor , 1996 .

[11]  J. Dunitz Organic Fluorine: Odd Man Out , 2004, Chembiochem : a European journal of chemical biology.